Ng-monomethyl-L-arginine (drug)

( DrugBank: Arginine, L-arginine, NG-Monomethyl-L-arginine / KEGG DRUG: Arginine, Arginine )

1 disease

ID	Disease name (Link within this page)	Number of trials
67	Polycystic kidney disease	1

67. Polycystic kidney disease

Clinical trials : 221 / Drugs : 212 - (DrugBank : 55) / Drug target genes : 40 - Drug target pathways : 151

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00345137 (ClinicalTrials.gov)	May 2006	24/6/2006	Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease an ...	Phase 1 Study of Systemic Effects of Ng-Monomethyl-L-Arginine on Renal Hemodynamics in Patients With ...	ADPKD;Glomerulonephritis	Drug: Ng-monomethyl-L-arginine (drug)	Regional Hospital Holstebro	NULL	Completed	20 Years	60 Years	Both	75	Phase 1	NULL

First Previous1Next Last